Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate safety and efficacy of vildagliptin versus NPH insulin
add-on to glimepiride in patients with type 2 diabetes mellitus that do not reach adequate
glycemic control on their current sulfonylurea monotherapy to give treating physicians a
guidance which additional anti-diabetic treatment can be used if sulfonylurea monotherapy is
not sufficient to reach glycemic control.